Treating cancer pain in dogs and cats

Veterinary Medicine

Volumn 100, Issue 5, 2005, Pages 364-380

  De Lorimier, Louis Philippe ^a   Fan, Timothy M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMANTADINE; AMITRIPTYLINE; ANAFEN; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ARTHRICARE; BISPHOSPHONIC ACID DERIVATIVE; BUPRENORPHINE; BUTORPHANOL; CARPROFEN; CLOMIPRAMINE; CODEINE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DERACOXIB; DERAMAXX; DEXAMETHASONE; ETODOLAC; ETOGESIC; FENTANYL; GABAPENTIN; HYDROMORPHONE; KETAMINE; KETOPROFEN; LIDOCAINE; MEDETOMIDINE; MELOXICAM; METHADONE; MEXILETINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYMORPHONE; PAMIDRONIC ACID; PARACETAMOL; PIROXICAM; PREDNISONE; SODIUM CHANNEL BLOCKING AGENT; TEPOXALIN; TILETAMINE; TOLFENAMIC ACID; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VINCRISTINE; XYLAZINE; ZUBRIN;

ACUPUNCTURE; AMPUTATION; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER RADIOTHERAPY; CANCER SURGERY; CREATININE BLOOD LEVEL; CRYOTHERAPY; DISEASE SEVERITY; ELECTROSTIMULATION; HYDROTHERAPY; HYPERTHERMIC THERAPY; LOW LEVEL LASER THERAPY; MASSAGE; MASTOCYTOMA; MULTIMODALITY CANCER THERAPY; NERVE STIMULATION; NEUROPATHIC PAIN; NONHUMAN; PLAY THERAPY; QUALITY OF LIFE; RADIATION DOSE; REVIEW; SPECIES COMPARISON; ULTRASOUND; UREA NITROGEN BLOOD LEVEL;

CANIS FAMILIARIS;

EID: 20444456711     PISSN: 87507943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Foley KM. Management of cancer pain. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 6th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2001;2977-3011.
2. Bruera ED, Portenoy RK. Cancer pain: assessment and management. Cambridge, UK: Cambridge University Press, 2003.
3. Slavin KV, Tesoro EP, Mucksavage JJ. The treatment of cancer pain. Drugs Today 2004;40:235-245.
4. Lussier D, Huskey AG, Portenoy RK. Adjuvant analgesics in cancer pain management. Oncologist 2004;9:571-591.
5. Patt RB, Lang SS. The complete guide to relieving cancer pain and suffering. New York, NY: Oxford University Press, 2004.
6. Collective work. American Cancer Society's guide to pain control: understanding and managing cancer pain. Atlanta, Ga: American Cancer Society Health Promotions, 2004.
7. Fine PG, Miaskowski C, Paice JA. Meeting the challenges in cancer pain management. J Support Oncol 2004;2(6 suppl 2):5-22.
8. Gaynor JS. Pain management for the oncology patient. In: Withrow SJ, MacEwen EG, eds. Small animal clinical oncology. 3rd ed. Philadelphia, Pa: WB Saunders, 2001;219-232.
9. Gaynor JS, Muir WW. Handbook of veterinary pain management. St. Louis, Mo: Mosby, 2002.
10. Kyles AE, Ruslander D. Chronic pain: osteoarthritis and cancer. Semin Vet Med Surg (Small Anim) 1997;12:122-132.
11. Lascelles BD. Relief of chronic cancer pain. In: Dobson J, Lascelles BD, eds. BSAVA manual of oncology. 2nd ed. Cheltenham, UK: BSAVA Publications, 2003;137-151.
12. Lester P, Gaynor JS. Management of cancer pain. Vet Clin North Am Small Anim Pract 2000;30:951-966.
13. O'Brien MG. Cancer pain management: a review of recent considerations and advancements. Vet Cancer Soc Newsletter 1998;22:1-6.
14. Tranquilli WJ, Grimm KA, Lamont LA. Pain management for the small animal practitioner. 2nd ed. Jackson, Wyo: Teton NewMedia, 2004.
15. Liptak JM, Monnet E, Dernell WS, et al. Pulmonary metastatectomy in the management of four dogs with hypertrophic osteopathy. Vet Comp Oncol 2004;2:1-12.
16. Bateman KE, Catton PA, Pennock PW, et al. 0-7-21 radiation therapy for the palliation of advanced cancer in dogs. J Vet Intern Med 1994;8:394-399.
17. Green EM, Adams WM, Forrest LJ. Four fraction palliative radiotherapy for osteosarcoma in 24 dogs. J Am Anim Hosp Assoc 2002;38:445-451.
18. McEntee MC. Radiation therapy in the management of bone tumors. Vet Clin North Am Small Anim Pract 1997;27:131-138.
19. Ramirez O 3rd, Dodge RK, Page RL, et al. Palliative radiotherapy of appendicular osteosarcoma in 95 dogs. Vet Radiol Ultrasound 1999;40:517-522.
20. Siegel S, Cronin KL. Palliative radiotherapy. Vet Clin North Am Small Anim Pract 1997;27:149-155.
21. Thrall DE, LaRue SM. Palliative radiation therapy. Semin Vet Med Surg (Small Anim) 1995;10:205-208.
22. Jones PD, de Lorimier LP, Kitchell BE, et al. Gemcitabine as a radiosensitizer for nonresectable feline oral squamous cell carcinoma. J Am Anim Hosp Assoc 2003;39:463-467.
23. Bateman KE, Catton PA, Pennock PW, et al. 0-7-21 radiation therapy for the treatment of canine oral melanoma. J Vet Intern Med 1994;8:267-272.
24. Dobson J, Cohen S, Gould S. Treatment of canine mast cell tumours with prednisolone and radiotherapy. Vet Comp Oncol 2004;2:132-141.
25. LaRue SM, Gillette EL. Radiation therapy. In: Withrow SJ, MacEwen EG, eds. Small animal clinical oncology. 3rd ed. Philadelphia, Pa: WB Saunders, 2001;119-137.
26. Freeman KP, Hahn KA, Harris FD, et al. Treatment of dogs with oral melanoma by hypofractionated radiation therapy and platinum-based chemotherapy (1987-1997). J Vet Intern Med 2003;17:96-101.
27. Klein MK. Multimodality therapy for head and neck cancer. Vet Clin North Am Small Anim Pract 2003;33:615-628.
28. Doré M, Lanthier I, Sirois J. Cyclooxygenase-2 expression in canine mammary tumors. Vet Pathol 2003;40:207-212.
29. Mohammed SI, Khan KN, Sellers RS, et al. Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer. Prostaglandins Leukot Essent Fatty Acids 2004;70:479-483.
30. Kleiter M, Malarkey DE, Ruslander DE, et al. Expression of cyclooxygenase-2 in canine epithelial nasal tumors. Vet Radiol Ultrasound 2004;45:255-260.
31. Mullins MN, Lana SE, Dernell WS, et al. Cyclooxygenase-2 expression in canine appendicular osteosarcomas. J Vet Intern Med 2004;18:859-865.
32. Khan KN, Stanfield KM, Trajkovic D, et al. Expression of cyclooxygenase-2 in canine renal cell carcinoma. Vet Pathol 2001;38:116-119.
33. Khan KN, Knapp DW, Denicola DB, et al. Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs. Am J Vet Res 2000;61:478-481.
34. Tremblay C, Doré M, Bochsler PN, et al. Induction of prostaglandin G/H synthase-2 in a canine model of spontaneous prostatic adenocarcinoma. J Natl Cancer Inst 1999;91:1398-1403.
35. Sorenmo KU, Goldschmidt MH, Shofer FS, et al. Evaluation of cyclooxygenase-1 and cyclooxygenase-2 expression and the effect of cyclooxygenase inhibitors in canine prostatic carcinoma. Vet Comp Oncol 2004;2:13-23.
36. Pestili de Almeida EM, Piché C, Sirois J, et al. Expression of cyclo-oxygenase-2 in naturally occurring squamous cell carcinomas in dogs. J Histochem Cytochem 2001;49:867-875.
37. McEntee MF, Cates JM, Neilsen N. Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs. Vet Pathol 2002;39:428-436.
38. Borzacchiello G, Paciello O, Papparella S. Expression of cyclooxygenase-1 and -2 in canine nasal carcinomas. J Comp Pathol 2004;131:70-76.
39. Mohammed SI, Craig BA, Mutsaers AJ, et al. Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Mol Cancer Ther 2003;2:183-188.
40. Knapp DW, Glickman NW, Widmer WR, et al. Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer. Cancer Chemother Pharmacol 2000;46:221-226.
41. Schmidt BR, Glickman NW, DeNicola DB, et al. Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs. J Am Vet Med Assoc 2001;218:1783-1786.
42. Boria PA, Murry DJ, Bennett PF, et al. Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs. J Am Vet Med Assoc 2004;224:388-394.
43. Henry CJ, McCaw DL, Turnquist SE, et al. Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma. Clin Cancer Res 2003;9:906-911.
44. Knapp DW, Richardson RC, Chan TC, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1994;8:273-278.
45. Robertson SA, Taylor PM. Pain management in cats - past, present and future. Part 2. Treatment of pain - clinical pharmacology. J Feline Med Surg 2004;6:321-333.
46. Heeb HL, Chun R, Koch DE, et al. Single dose pharmacokinetics of piroxicam in cats. J Vet Pharmacol Ther 2003;26:259-263.
47. Slingsby LS, Waterman-Pearson AE. Comparison between meloxicam and carprofen for postoperative analgesia after feline ovariohysterectomy. J Small Anim Pract 2002;43:286-289.
48. Wilson DV, Evans AT, Miller R. Effects of preanesthetic administration of morphine on gastroesophageal reflux and regurgitation during anesthesia in dogs. Am J Vet Res 2005;66:386-390.
49. Foss JF, Yuan CS, Roizen MF, et al. Prevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine. Cancer Chemother Pharmacol 1998;42:287-291.
50. Hofmeister EH, Egger CM. Transdermal fentanyl patches in small animals. J Am Anim Hosp Assoc 2004;40:468-478.
51. Lascelles BD, Robertson SA. Use of thermal threshold response to evaluate the antinociceptive effects of butorphanol in cats. Am J Vet Res 2004;65:1085-1089.
52. Lascelles BD, Robertson SA. Antinociceptive effects of hydromorphone, butorphanol, or the combination in cats. J Vet Intern Med 2004;18:190-195.
53. Robertson SA, Taylor PM, Lascelles BD, et al. Changes in thermal threshold response in eight cats after administration of buprenorphine, butorphanol and morphine. Vet Rec 2003;153:462-465.
54. Grond S, Radbruch L, Meuser T, et al. High-dose tramadol in comparison to low-dose morphine for cancer pain relief. J Pain Symptom Manage 1999;18:174-179.
55. Leppert W, Luczak J. The role of tramadol in cancer pain treatment - a review. Support Care Cancer 2005;13:5-17.
56. Wu WN, McKown LA, Gauthier AD, et al. Metabolism of the analgesic drug, tramadol hydrochloride, in rat and dog. Xenobiotica 2001;31:423-441.
57. KuKanich B, Papich MG. Pharmacokinetics of tramadol and the metabolite O-desmethyltramadol in dogs. J Vet Pharmacol Ther 2004;27:239-246.
58. Mastrocinque S, Fantoni DT. A comparison of preoperative tramadol and morphine for the control of early postoperative pain in canine ovariohysterectomy. Vet Anaesth Analg 2003;30:220-228.
59. Parker R. Pharm profile: tramadol. Compend Cont Educ Pract Vet 2004;26:800-802.
60. Radulovic LL, Turck D, von Hodenberg A, et al. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys. Drug Metab Dispos 1995;23:441-448.
61. Chew DJ, Buffington CA, Kendall MS, et al. Amitriptyline treatment for severe recurrent idiopathic cystitis in cats. J Am Vet Med Assoc 1998;213:1282-1286.
62. Fan TM, de Lorimier LP, Charney SC, et al. Evaluation of intravenous pamidronate administration in 33 cancer-bearing dogs with primary or secondary bone involvement. J Vet Intern Med 2005;19:74-80.
63. Milner RJ, Farese J, Henry CJ, et al. Bisphosphonates and cancer. J Vet Intern Med 2004;18:597-604.
64. Alimi D, Rubino C, Pichard-Léandri E, et al. Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. J Clin Oncol 2003;21:4120-4126.
65. Deng G, Cassileth BR, Yeung KS. Complementary therapies for cancer-related symptoms. J Support Oncol 2004;2:419-426.